August 7, 2008


Print photo (6.5 MB)
Patrick C. Walsh, M.D.

University Distinguished Service Professor of Urology
Johns Hopkins Medical Institutions


PUBLICATIONS
Free Access to abstracts at PubMed
  1. Walsh PC, Gittes RF. Inhibition by antiandrogens of the prostatic growth stimulated by adrenal androgens and pituitary prolactin in castrate rats. Surg Forum. 1969;20:518-9.

  2. Walsh PC, Swerdloff RS, Odell WD. Cryptorchism:effect on pituitary gonadotropin secretion in the rat. Surg Forum. 1970;21:530-2.

  3. Walsh PC, Gittes RF. Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens. Endocrinology. 1970 Sep;87(3):624-7.

  4. Walsh PC, Gittes RF, Lecky JW. Aortography in experimental renal failure. Evaluation of contrast media toxicity. Radiology. 1970 Oct;97(1):33-7.

  5. Swerdloff RS, Walsh PC, Jacobs HS, Odell WD. Serum LH and FSH during sexual maturation in the male rat:effect of castration and cryptorchidism. Endocrinology. 1971 Jan;88(1):120-8.

  6. Walsh PC, Korenman SG. Mechanism of androgenic action:effect of specific intracellular inhibitors. J Urol. 1971 Jun;105(6):850-7.

  7. Walsh PC, Kaufman JJ, Coulson WF, Goodwin WE. Retroperitoneal lymphadenectomy for testicular tumors. JAMA. 1971 Jul 19;217(3):309-12.

  8. Walsh PC, Swerdloff RS. Testosterone:effect on rat testis. Surg Forum. 1972;23(0):522- 3.

  9. Walsh PC, Swerdloff RS, Odell WD. Cyproterone:effect on serum gonadotropins in the male. Endocrinology. 1972 Jun;90(6):1655-9.

  10. Swerdloff RS, Walsh PC, Odell WD. Control of LH and FSH secretion in the male:Evidence that aromatization of androgens to estradiol is not required for inhibition of gonadotropin secretion. Steroids. 1972 Jul;20(1):13-22.

  11. Walsh PC, Swerdloff RS. Experimental cryptorchism:effect on serum LH and FSH in the rat. Urol Res. 1973 Jan;1(1):22-6.

  12. Constantinople NL, Walsh PC. Activity of mullerian-inhibiting substance in postnatal testes. Surg Forum. 1973;24:538-9.

  13. Swerdloff RS, Walsh PC. Testosterone and oestradiol suppression of LH and FSH in adult male rats:duration of castration, duration of treatment and combined treatment. Acta Endocrinol (Copenh). 1973 May;73(1):11-21.

  14. Walsh PC, Kaufman JJ, Smith RB, Goodwin WE. Percutaneous antegrade pyelography in hydronephrosis. Preoperative assessment. Urology. 1973 Jun;1(6):537-41.

  15. Saalfeld J, Walsh PC, Goodwin WE. Ureterovaginoplasty for vaginal atresia (unique technique in treatment):a case report with description of associated arterial anomalies and retroiliac artery ureters. J Urol. 1973 Jun;109(6):1039-45.

  16. Smith RB, Walsh PC, Goodwin WE. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol. 1973 Jul;110(1):106-8.

  17. Walsh PC, Swerdloff RS, Odell WD. Feedback regulation of gonadotropin secretion in men. J Urol. 1973 Jul;110(1):84-9.

  18. Khudr G, Walsh PC, Benirschke K. Quinacrine fluorescence of testicular tumors. Urology. 1973 Aug;2(2):162-4.

  19. Walsh PC, Swerdloff RS. Biphasic effect of testosterone on spermatogenesis in the rat. Invest Urol. 1973 Nov;11(3):190-3.

  20. Walsh PC, Swerdloff RS, Odell WD. Feedback control of FSH in the male:role of oestrogen. Acta Endocrinol (Copenh). 1973 Nov;74(3):449-60.

  21. Piconi JR, Henry SC, Walsh PC. Rapid development of carcinoma in diverticulum of the bladder. A pitfall in conservative management. Urology. 1973 Dec;2(6):676-7.

  22. Walsh, P.C. Antiandrogens: Mechanism of action and cliical applications. Actuelle Urologie 4:189-196, 1973.

  23. Cochran JS, Walsh PC, Porter JC, Nicholson TP, Peters PC. Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. Surg Forum. 1974;25(0):542-3.

  24. Henry SC, Walsh PC, Rotner MB. Choriocarcinoma of the testis. J Urol. 1974 Jul;112(1):105-8.

  25. Nicholson TC, Walsh PC, Rotner MB. Lymphadenectomy combined with preoperative and postoperative cobalt 60 teletherapy in the management of embryonal carcinoma and teratocarcinoma of the testis. J Urol. 1974 Jul;112(1):109-10.

  26. Hill DR, Crews QE Jr, Walsh PC. Prostate carcinoma:radiation treatment of the primary and regional lymphatics. Cancer. 1974 Jul;34(1):156-60.

  27. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 1974 Oct 31;291(18):944-9.

  28. Walsh PC. Physiologic basis for hormonal theapy in carcinoma of the prostate. Urol Clin North Am. 1975 Feb;2(1):125-40.

  29. Walsh PC, Siiteri PK. Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. J Urol. 1975 Aug;114(2):254-6.

  30. Cochran JS, Walsh PC, Porter JC, Nicholson TC, Madden JD, Peters PC. The endocrinology of human chorionic gonadotropin-secreting testicular tumors:new methods in diagnosis. J Urol. 1975 Oct;114(4):549-55.

  31. Madden JD, Walsh PC, MacDonald PC, Wilson JD. Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization. J Clin Endocrinol Metab. 1975 Oct;41(4):751-60.

  32. Swerdloff RS, Walsh PC. Pituitary and gonadal hormones in patients with varicocele. Fertil Steril. 1975 Oct;26(10):1006-12.

  33. Catt KJ, Dufau ML, Neaves WB, Walsh PC, Wilson JD. LH-hCG receptors and testosterone content during differentiation of the testis in the rabbit embryo. Endocrinology. 1975 Nov;97(5):1157-65.

  34. Walsh, P.C. and Siiteri, P.J.: Spironolactone induced suppression of plasma testosterone, androstenedione, and dehydroepiandrosterone in orchiectomized men with carcinoma of the prostate, In Normal and Abnormal Growth of the Prostate, ed. M. Goland. Charles C. Thomas Publishers, Springfield, Illinois, 1975, pp. 846-849.

  35. Walsh, P.C.: Intersex States, Chapter 2, In Urological Surgery, Second Edition, eds., Glenn, J.F. and Boyce, W.H., Harper and Row, 1975.

  36. Walsh PC. Benign prostatic hyperplasia:etiological considerations. Prog Clin Biol Res. 1976;6:1-8.

  37. Walsh PC, McLoughlin MG, Menon M, Tananis C. Measurement of androgen receptors in human prostatic tissue:methodological considerations. Prog Clin Biol Res. 1976;6:159-68.

  38. Walsh PC, Curry N, Mills RC, Siiteri PK. Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocrinol Metab. 1976 Jan;42(1):52-9.

  39. Sloan WR, Walsh PC. Familial persistent Mullerian duct syndrome. J Urol. 1976 Apr;115(4):459-61.

  40. Walsh PC, Wilson JD. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest. 1976 Apr;57(4):1093-7.

  41. Clyde HR, Walsh PC, English RW. Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism. Fertility & Sterility. 1976 Jun;27(6):662-6.

  42. Wilson, J.D., Walsh, P.C. and Siiteri, P.K.: Studies on the pathogenesis of BPH in the dog, In Benign Prostatic Hyperplasia, J.T. Grayhack, J.D. Wilson, and M.J. Scherbenski, (eds.) DHEW Publication No. (NIH) 76-1113, pp. 205-11, 1976.

  43. Walsh, P.C.: Experimental approaches to benign prostatic hypertrophy: Animal models utilizing the dog, rat, and mouse, In Benign Prostatic Hyperplasia, J.T. Grayhack, J.D. Wilson, and M.J. Scherbenske, (eds.) DHEW Publication No (NIH) 76-1113, pp. 215-22.

  44. Rajfer J, Walsh PC. The incidence of intersexuality in patients with hypospadias and cryptorchidism. J Urol. 1976 Dec;116(6):769-70.

  45. Walsh PC, Greco JM, Tananis CE, Hicks LL, McLoughlin MG, Menon M. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer. Trans Am Assoc Genitourin Surg. 1977;69:78-80.

  46. Rajfer J, Coffey DS, Walsh PC. Effects of hormones in the newborn period on the development of the penis. Surg Forum. 1977;28:570-3.

  47. Walsh PC. The endocrinology of testicular tumors. Recent Results Cancer Res. 1977;(60):196-201.

  48. Rajfer J, Walsh PC. Testicular descent. Birth Defects Orig Artic Ser. 1977;13(2):107-22. Review.

  49. Menon M, Tananis CE, McLoughlin MG, Lippman ME, Walsh PC. The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay. J Urol. 1977 Mar;117(3):309-12.

  50. Menon M, Tananis CE, McLoughlin MG, Walsh PC. Androgen receptors in human prostatic tissues:a review. Cancer Treat Rep. 1977 Mar-Apr;61(2):265-71. Review.

  51. Marshall FF, Walsh PC. Extrarenal manifestations of renal cell carcinoma. J Urol. 1977 Apr;117(4):439-40.

  52. Amrhein JA, Klingensmith GJ, Walsh PC, McKusick VA, Migeon CJ. Partial androgen insensitivity:the Reifenstein syndrome revisited. N Engl J Med. 1977 Aug 18;297(7):350-6.

  53. Rajfer J, Walsh PC. Hormonal regulation of testicular descent:experimental and clinical observations. J Urol. 1977 Dec;118(6):985-90.

  54. Sanders RC, Duffy T, Mcloughlin MG, Walsh PC. Sonography in the diagnosis of retroperitoneal fibrosis. J Urol. 1977 Dec;118(6):944-6.

  55. Coffey, D.S., DeKlerk, D.P., and Walsh, P.C.: Benign prostatic hyperplasia: Current Concepts. Excerpta Medical International Congress Series No. 403, Endocrinologoy Proceedings of the V International Congress of Endocrinology, Hamburg, July 18-24, 1976. Vol. 2:495-99, 1977.

  56. Walsh, P.C. and Amelar, R.D.: Embryology, anatomy, and physiology of the male reproductive system. In Male Infertility, eds. R.D. Amelar, L. Dubin, P.C. Walsh, W.B. Saunders, Philadelphia, 1977, pp. 3-32.

  57. Walsh, P.C.: Endocrine and chromosomal factors associated with infertility. Ibid. pp. 33- 56.

  58. Walsh, P.C.: Endocrine evaluation of the infertile male. Ibid. pp. 153-58.

  59. Walsh, P.C. and Amelar, R.D.: Medical management of male infertility. Ibid. pp. 179-90.

  60. Menon M, Tananis CE, Hicks LL, Hawkins EF, McLoughlin MG, Walsh PC. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues. J Clin Invest. 1978 Jan;61(1):150-62.

  61. Rajfer J, Walsh PC. Testicular descent. Normal and abnormal. Urol Clin North Am. 1978 Feb;5(1):223-35. Review.

  62. Walsh PC. The differential diagnosis of ambiguous genitalia in the newborn. Urol Clin North Am. 1978 Feb;5(1):213-21.

  63. Rajfer J, Eggleston JC, Sanders RC, Walsh PC. Fever and prostatic mass in a young man. J Urol. 1978 Apr;119(4):555-8.

  64. Rajfer J, Mendelsohn G, Arnheim J, Jeffs RD, Walsh PC. Dysgenetic male pseudohermaphroditism. J Urol. 1978 Apr;119(4):525-7.

  65. Walsh PC, Migeon CJ. The phenotypic expression of selective disorders of male sexual differentiation. J Urol. 1978 May;119(5):627-9.

  66. Walsh PC, Wilson JD, Allen TD, Madden JD, Porter JC, Neaves WB, Griffin JE, Goodwin WE. Clinical and endocrinological evaluation of patients with congenital microphallus. J Urol. 1978 Jul;120(1):90-5.

  67. Michigan S, Whelton PK, Walsh PC. Forgotten kidney:asynchronous bilateral ureteropelvic junction obstruction. Urology. 1978 Nov;12(5):565-6.

  68. McPhee SJ, Katz RD, Olson JL, Walsh PC. Clinical conferences at the Johns Hopkins Hospital. Prostatic carcinoma. Johns Hopkins Med J. 1978 Dec;143(6):207-11.

  69. Walsh PC, Hicks LL. Characterization and measurement of androgen receptors in human prostatic tissue. Prog Clin Biol Res. 1979;33:51-63.

  70. Heston WD, Menon M, Tananis C, Walsh PC. Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor. Cancer Lett. 1979 Jan;6(1):45-50.

  71. Walsh PC. A new cause of male infertility. N Engl J Med. 1979 Feb 1;300(5):253-4.

  72. Reiner WG, Walsh PC. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol. 1979 Feb;121(2):198-200.

  73. Hicks LL, Walsh PC. A microassay for the measurement of androgen receptors in human prostatic tissue. Steroids. 1979 Apr;33(4):389-406.

  74. Davies TF, Walsh PC, Hodgen GD, Dufau ML, Catt KJ. Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells. J Clin Endocrinol Metab. 1979 Apr;48(4):680-5.

  75. Lepor H, Walsh PC. Idiopathic retroperitoneal fibrosis. J Urol. 1979 Jul;122(1):1-6. Review.

  76. Reiner WG, Scott WW, Eggleston JC, Walsh PC. Long-term survival after hormonal therapy for stage D prostatic cancer. J Urol. 1979 Aug;122(2):183-4.

  77. DeKlerk DP, Coffey DS, Ewing LL, McDermott IR, Reiner WG, Robinson CH, Scott WW, Strandberg JD, Talalay P, Walsh PC, Wheaton LG, Zirkin BR. Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1979 Sep;64(3):842-9.

  78. Walsh PC, Hensle T, Wigger HJ. Ambiguous genitalia in a child. Urology. 1979 Oct;14(4):405-10.

  79. Whelton PK, Harris AP, Russell RP, Walsh PC, Williams GM, Harrington DP, Walker WG. Renovascular hypertension:comparison of medical and surgical therapy. Clin Sci (Lond). 1979 Dec;57 Suppl 5:445s-447s.

  80. Walsh, P.C. and Scott, W.W.: Intersex. In Pediatric Surgery, (eds) M.M. Ravitch, K.J., Welch, C.D., Benson, E. Aberdeen, J.G. Randolph. Chicago Year Book Medical Publishers, Inc., 1979, pp. 1411-25.

  81. Walsh, P.C.: Benign prostatic hyperplasia. In Campbell’s Urology, (eds) J.H. Harrison, R.F. Gittes, T.A. Stamey, A.D. Perlmutter, P.C. Walsh. Philadelphia, W.B. Saunders, 1979, pp. 949-64

  82. Wilson, J.D. and Walsh, P.C.: disorders of sexual differentiation. Ibid. Pp. 1484-1532.

  83. Menon, M. And Walsh, P.C.: Hormonal therapy for prostatic cancer. In Prostatic Cancer (eds) G.P. Murphy. PSG Publishing Company, Inc. Littleton, MA 1979, pp. 175-200.

  84. Zwartendijk, J. and Walsh, P.C.: Radical retropubic prostatectomy. In Current and Future Trends in Urology, edited by by S.I. Miranda and H.J. de Voogt, Bunge Scientific Publishers, pp. 102-110, 1979.

  85. Zerhouni EA, Siegelman SS, Walsh PC, White RI. Elevated pressure in the left renal vein in patients with varicocele:preliminary observations. J Urol. 1980 Apr;123(4):512-3.

  86. Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer. 1980 Apr 15;45(7 Suppl):1906-11.

  87. Scott WW, Menon M, Walsh PC. Hormonal therapy of prostatic cancer. Cancer. 1980 Apr 15;45(7 Suppl):1929-36.

  88. Rosenshein NB, Lichter AS, Walsh PC. Cervical cancer complicated by a pelvic kidney. J Urol. 1980 May;123(5):766-7.

  89. Trachtenberg J, Hicks LL, Walsh PC. Androgen and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1980 May;65(5):1051-9.

  90. Walsh, P.C. and Wilson, J.D.: disturbances of sexual function and reproduction in men. In Harrison’s Principles of Internal Medicine, (eds) K.J. Isselbacher, R.D. Adams, E. Braunwald, R.B. Petersdorf, and J.D. Wilson. McGraw-Hill, New York, 1980, pp. 229-232.

  91. Murphy JB, Emmott RC, Hicks LL, Walsh PC. Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin:a marker for estrogen-responsive tissues? J Clin Endocrinol Metab. 1980 May;50(5):938-48.

  92. Walsh PC. Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am. 1980 Oct;7(3):583-91.

  93. Howards SS, Walsh PC. Radioimmunoassay for prostatic acid phosphatase. J Urol. 1980 Nov;124(5):753-4.

  94. Schmeller NT, Siegelman SS, Walsh PC. Anatomical considerations in suprahilar lymph node dissection for testicular tumors. Urol Int. 1981;36(6):341-5.

  95. Hawkins, E.F., Trachtenberg, J., Hicks, L.L., and Walsh, P.C.: Androgen and estrogen receptors in the canine prostate. J. of Androl. 1980; l(1), #5:234-43.

  96. Trachtenberg J, Hicks LL, Walsh PC. Methods for the determination of androgen receptor content in human prostatic tissue. Invest Urol. 1981 Mar;18(5):349-54.

  97. Walsh, P.C., Tyson, J.E.A., Hsu, T.H.: The gonads. In The Principles and Practice of Medicine, Twentieth Edition, (eds) A.M. Harvey, R.J. Johns, V.A. McKusick, A.H. Owens, Jr., R.S. Ross, Appleton-Century Croft, New York, 1980, pp. 893-918.

  98. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC. Pathological factors that influence prognosis in stage A prostatic cancer:the influence of extent versus grade. J Urol. 1981 Apr;125(4):516-20.

  99. White RI Jr, Kaufman SL, Barth KH, Kadir S, Smyth JW, Walsh PC. Occlusion of varicoceles wih detachable balloons. Radiology. 1981 May;139(2):327-34.

  100. Fichman KR, Nyberg LM, Bujnovszky P, Brown TR, Walsh PC. The ontogeny of the androgen receptor in human foreskin. J Clin Endocrinol Metab. 1981 May;52(5):919-23.

  101. Walsh PC. Randomized study of prostatic cancer. Urology. 1981 Aug;18(2):219-20.

  102. Ehrlichman RJ, Kaufman SL, Siegelman SS, Trump DL, Walsh PC. Computerized tomography and lymphangiography in staging testis tumors. J Urol. 1981 Aug;126(2):179-81.

  103. Feinstein RS, Gatewood OM, Goldman SM, Copeland B, Walsh PC, Siegelman SS. Computerized tomography in the diagnosis of retroperitoneal fibrosis. J Urol. 1981 Aug;126(2):255-9.

  104. Walsh PC, White RI Jr. Balloon occlusion of the internal spermatic vein for the treatment of varicoceles. JAMA. 1981 Oct 9;246(15):1701-2.

  105. Whelton PK, Harris AP, Russell RP, Walsh PC, Williams GM, Harrington DP, Walker WG. Renovascular hypertension:results of medical and surgical therapy. Johns Hopkins Med J. 1981 Dec;149(6):213-9.

  106. Elder JS, Isaacs JT, Walsh PC. Androgenic sensitivity of the gubernaculum testis:evidence for hormonal/mechanical interactions in testicular descent. J Urol. 1982 Jan;127(1):170-6.

  107. Trachtenberg J, Bujnovszky P, Walsh PC. Androgen receptor content of normal and hyperplastic human prostate. J Clin Endocrinol Metab. 1982 Jan;54(1):17-21.

  108. Trachtenberg J, Walsh PC. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol. 1982 Mar;127(3):466-71.

  109. Elder JS, Jewett HJ, Walsh PC. Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol. 1982 Apr;127(4):704-6.

  110. Goldman SM, Gatewood OM, Walsh PC, Dornhorst A, Siegelman SS. CT configuration of the enlarged adrenal gland. J Comput Assist Tomogr. 1982 Apr;6(2):276-80.

  111. Bias WB, Nyberg LM Jr, Hochberg MC, Walsh PC. Peyronie's disease:a newly recognized autosomal-dominant trait. Am J Med Genet. 1982 Jun;12(2):227-35.

  112. Nyberg LM Jr, Bias WB, Hochberg MC, Walsh PC. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol. 1982 Jul;128(1):48-51.

  113. Lepor H, Ross A, Walsh PC. The influence of hormonal therapy on survival of men with advanced prostatic cancer. J Urol. 1982 Aug;128(2):335-40.

  114. Walsh PC, Donker PJ. Impotence following radical prostatectomy:insight into etiology and prevention. J Urol. 1982 Sep;128(3):492-7.

  115. Ekman P, Barrack ER, Walsh PC. Simultaneous measurement of progesterone and androgen receptors in human prostate:a microassay. J Clin Endocrinol Metab. 1982 Dec;55(6):1089-99.

  116. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function:anatomical and pathological considerations. Prostate. 1983;4(5):473-85.

  117. Isaacs JT, Brendler CB, Walsh PC. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab. 1983 Jan;56(1):139-46.

  118. Walsh, P.C. and Wilson, Jean D.: Disturbances of sexual and reproductive function in men. In Harrison’s Principles of Internal Medicine, 10th Edition, (eds) Petersdorf, Adams, Braunwald, Isselbiacher, Martin, and Wilson, McGraw-Hill, New York, 1983, pp. 240-43.

  119. Barrack ER, Bujnovszky P, Walsh PC. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues:characterization of nuclear salt-resistant receptors. Cancer Res. 1983 Mar;43(3):1107-16.

  120. Kaufman SL, Kadir S, Barth KH, Smyth JW, Walsh PC, White RI Jr. Mechanisms of recurrent varicocele after balloon occlusion or surgical ligation of the internal spermatic vein. Radiology. 1983 May;147(2):435-40.

  121. Brendler CB, Berry SJ, Ewing LL, McCullough AR, Cochran RC, Strandberg JD, Zirkin BR, Coffey DS, Wheaton LG, Hiler ML, Bordy MJ, Niswender GD, Scott WW, Walsh PC. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest. 1983 May;71(5):1114-23.

  122. Ekman P, Barrack ER, Greene GL, Jensen EV, Walsh PC. Estrogen receptors in human prostate:evidence for multiple binding sites. J Clin Endocrinol Metab. 1983 Jul;57(1):166-76.

  123. Droller MJ, Walsh PC. Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer? Urology. 1983 Aug;22(2):118-22.

  124. Walsh PC, Hutchins GM, Ewing LL. Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal. J Clin Invest. 1983 Nov;72(5):1772-7.

  125. Walsh PC. Human benign prostatic hyperplasia:etiological considerations. Prog Clin Biol Res. 1984;145:1-25. Review.

  126. Brendler CB, Isaacs JT, Follansbee AL, Walsh PC. The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate:a preliminary report. J Urol. 1984 Apr;131(4):694-700.

  127. Marshall FF, Walsh PC. In situ management of renal tumors:renal cell carcinoma and transitional cell carcinoma. J Urol. 1984 Jun;131(6):1045-9.

  128. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984 Sep;132(3):474-9.

  129. Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol. 1984 Dec;56(6):694-7.

  130. Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa:a detailed anatomical study of the adult male pelvis. J Urol. 1985 Feb;133(2):207-12.

  131. Walsh, P.C.: Diseases of the prostate. In Cecil’s Textbook of Medicine, 17th Edition (eds) Wyngaarden and Smith, W B. Saunders, Philadelphia, PA, 1985, pp. 1375-79.

  132. Peters CA, Walsh PC. Blood transfusion and anesthetic practices in radical retropubic prostatectomy. J Urol. 1985 Jul;134(1):81-3.

  133. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function:pathological findings in the first 100 cases. J Urol. 1985 Dec;134(6):1146-8.

  134. Droller MJ, Walsh PC. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ:is it safe? J Urol. 1985 Dec;134(6):1115-7.

  135. Dahnert WF, Hamper UM, Eggleston JC, Walsh PC, Sanders RC. Prostatic evaluation by transrectal sonography with histopathologic correlation:the echopenic appearance of early carcinoma. Radiology. 1986 Jan;158(1):97-102.

  136. Walsh, P.C.: Benign Prostatic Hyperplasia. In Campbell’s Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Gittes, R.F., Perlmutter, A.D., and Stamey, T.A., WlB. Saunders, Philadelphia, 1986, Vol. 2, pp. 1248-1265.

  137. Walsh, P.C.: Radical retropubic prostatectomy. In Campbell’s Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Gittes, R.F., Perlmutter, A.D., and Stamey, T.A., W.B. Walsh PC. Saunders, Philadelphia, 1986, vol. 3, pp. 2754-2775.

  138. Walsh, P.C.: Radical prostatectomy and cystoprostatectomy with preservation of potency using a nerve-sparing technique. In Current Urologic Therapy, 2nd Edition (ed) J.J. Kaufman. W.B. Saunders, Philadelphia, 1986, pp. 331-333.

  139. Walsh, P.C.: Radical prostatectomy with preservation of sexual function: Evolution of a surgical procedure. AUA UPDATE SERIES, Lesson 5, Vol. V:1-8, 1986.

  140. Walsh, P.C.: Radical retropubic prostatectomy– An anatomic approach with preservation of sexual function. A pictorial review of urologic procedures. Presented by Bristol Laboratories, LTI Medica, New Scotland, NY 1986.

  141. Walsh, P.C.: Fine needle aspiration of the prostate--why has it taken so long to accept? J Urol. 1986 Feb;135(2):334-5.

  142. Dahnert WF, Hamper UM, Walsh PC, Eggleston JC, Sanders RC. The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation. Radiology. 1986 Apr;159(1):95-100.

  143. Benson MC, Walsh PC. The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer:preliminary results. J Urol. 1986 Jun;135(6):1194-8.

  144. Jarow JP, Berkovitz GD, Migeon CJ, Gearhart JP, Walsh PC. Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism. J Urol. 1986 Jul;136(1 Pt 2):277-9.

  145. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage A1 prostatic carcinoma:a study of 94 cases with extended followup. J Urol. 1986 Oct;136(4):837-9.

  146. Hamper UM, Dahnert WF, Eggleston JC, Walsh PC, Sanders RC. Ultrasonography of prostatic carcinoma employing amplitude-enveloped (AM) and frequency-demodulated (FM) imaging:in vivo, in vitro, and pathologic correlation. J Ultrasound Med. 1986 Oct;5(10):557-62.

  147. Walsh, P.C. and Wilson, Jean D.: Impotence and infertility in men. In Harrison’s Principles of Internal Medicine, 11th Edition, (eds) Braunwald, Isselbacher, Petersdorf, Wilson, Martin and Fauci, McGraw-Hill, New York, 1986, pp. 217-20.

  148. Makofski, R.A., Massey, J.T., Mark, F.F., Weiskopf, Jr., F.B., Guier, W.H., Walsh, P.C. and Marshall, F.F.: Means and method for the non-invasive fragmentation of body concretions. United States Patent #4,610,249 dated September 9, 1986.

  149. Oesterling JE, Epstein JI, Walsh PC. The inability of adrenal androgens to stimulate the adult human prostate:an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism. J Urol. 1986 Nov;136(5):1030-4.

  150. Epstein, J.I. and Walsh, P.C.: Stage A prostate cancer is incidental but not insignificant. In Problems in Urology, Vol. 1, No. 1, (ed) Paulson, D., J.B. Lippincott Co., January/March 1987, Philadelphia, pp. 34-41.

  151. Walsh, P.C. and Epstein, J.I.: Radical prostatectomy with preservation of sexual function: Impact on cancer control. In Problems of Urology, Vol. 1, No. 1, (ed) Paulson, D., J. B. Lippincott Co., January/March 1987, Philadelphia, pp. 42-52.

  152. Epstein JI, Oesterling JE, Eggleston JC, Walsh PC. Frozen section detection of lymph node metastases in prostatic carcinoma:accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol. 1986 Dec;136(6):1234-7.

  153. Lepor H. and Walsh PC. The role of radical prostatectomy in the management of stage B adenocarcinoma of the prostate. Prog Clin Biol Res. 1987;243B:343-56. Review.

  154. Lepor, H. and Walsh, P.C.: Stage B1 prostatic adenocarcinoma. In Current Therapy in Genitourinary Surgery, (eds) Resnick and Kursh. B.C. Decker, Inc. Toronto-Philadelphia, pp. 92-95, 1987.

  155. Barrack ER, Brendler CB, Walsh PC. Steroid receptor and biochemical profiles in prostatic cancer: Correlation with response to hormonal treatment. In: Prog Clin Biol Res. 243A Prostate Cancer Part A: Research, Endocrine Treatment and Histopathology, (eds) G.P. Murphy, S. Khoury, R. Kuss, C. Chatelain and L. Denis, Alan R. Liss, Inc., New York, pp. 79-97 (1987).

  156. Oesterling JE, Epstein JI, Walsh PC. Long-term autopsy findings following radical prostatectomy. Urology. 1987 Jun;29(6):584-8.

  157. Schlegel PN, Walsh PC. Simultaneous preperitoneal hernia repair during radical pelvic surgery. J Urol. 1987 Jun;137(6):1180-3.

  158. Oesterling JE, Brendler CB, Epstein JI, Kimball AW Jr, Walsh PC. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol. 1987 Jul;138(1):92-8.

  159. Walsh PC, Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer. 1987 Aug 1;60(3 Suppl):526-37.

  160. Peters CA, Walsh PC. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med. 1987 Sep 3;317(10):599-604.

  161. Walsh PC, Epstein JI, Lowe FC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol. 1987 Oct;138(4):823-7.

  162. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh PC. Prostate-specific antigen as a marker for prostatic cancer:a monoclonal and a polyclonal immunoassay compared. Clin Chem. 1987 Oct;33(10):1916-20.

  163. Walsh PC. Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Urol Clin North Am. 1987 Nov;14(4):663-73. Review.

  164. Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987 Dec;138(6):1402-6.

  165. Walsh PC. Adjuvant radiotherapy after radical prostatectomy:is it indicated? J Urol. 1987 Dec;138(6):1427-8.

  166. Walsh, P.C.: Diseases of the Prostate. In Cecil Textbook of Medicine, 18th Edition. (Eds) Wyngaarden and Smith, W.B. Saunders, Philadelphia, PA 1988, pp. 1421-1425.

  167. Rock, R.C., Chan, D.W., Bruzek, D., Waldron, C., Oesterline, J.E., and Walsh, P.C.: Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin. Chem. 33:2257-2261, 1987.

  168. Walsh, P.C.: Technique of radical retropubic prostatectomy with preservation of sexual function–An anatomic approach. In Diagnosis and Management of Genitourinary Cancer, (eds) Skinnerand Lieskovsky, W.B. Saunders, Philadelphia, 1988, pp. 753-78.

  169. Walsh, P.C.: Radical retropubic prostatectomy: An anatomical approach with preservation of sexual function. In Current Operative Surgery, (ed) Mundy, Bailliere, Tindall, London, 1988, pp. 35-55.

  170. Walsh PC. Radical retropubic prostatectomy with reduced morbidity:an anatomic approach. NCI Monogr. 1988;(7):133-7.

  171. Lepor H, Walsh PC. Long-term results of radical prostatectomy in clinically localized prostate cancer:experience at the Johns Hopkins Hospital. NCI Monogr. 1988;(7):117-22.

  172. 172. Walsh PC. Preservation of sexual function in the surgical treatment of prostatic cancer--an anatomic surgical approach. Important Adv Oncol. 1988;:161-70. Review.

  173. Walsh PC. The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia. J Urol. 1988 Apr;139(4):826.

  174. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988 Apr;139(4):766-72.

  175. Epstein JI, Oesterling JE, Walsh PC. The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer. J Urol. 1988 May;139(5):975-9.

  176. Epstein JI, Oesterling JE, Walsh PC. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J Urol. 1988 May;139(5):980-4.

  177. Walsh PC. Nerve sparing radical prostatectomy for early stage prostate cancer. Semin Oncol. 1988 Aug;15(4):351-8.

  178. Marshall FF, Weiskopf F, Singh A, Mark F, Leo F, Sanders R, Makofski R, Walsh PC, Smith N. A prototype device for nonimmersion shock wave lithotripsy using ultrasonography for calculus localization. J Urol. 1988 Aug;140(2):249-53.

  179. Epstein, J.I. and Walsh, P.C.: The classification and prognosis of untreated stage A1 and A2 prostate cancer with a comparison of their histologic findings at radical prostatectomy. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer, (eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 295-97.

  180. Walsh, P.C., Oesterling, J.E., and Lepor, H.: Radical prostatectomy for the treatment of localized prostatic cancer. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer, (eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 123-40.

  181. Whitmore, Jr., W.F., Catalona, W.J., Grayhack, J.T., Hanks, G., Peters, P.C., Shipley, W.U., and Walsh, P.C.: Organ systems program staging classification for prostate cancer. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. (Eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 295-97.

  182. Walsh PC, Schlegel PN. Radical pelvic surgery with preservation of sexual function. Ann Surg. 1988 Oct;208(4):391-400.

  183. Walsh PC, Oesterling JE, Epstein JI, Bruzek DJ, Rock RC, Chan DW. The value of prostate-specific antigen in the management of localized prostatic cancer. Prog Clin Biol Res. 1989;303:27-33.

  184. Lepor H, Kimball AW, Walsh PC. Cause-specific actuarial survival analysis:a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J Urol. 1989 Jan;141(1):82-4.

  185. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 1989 Feb;141(2):341-5.

  186. Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC. The rat as a model for the study of penile erection. J Urol. 1989 Mar;141(3):656-61.

  187. Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol. 1989 Apr;141(4):987-92.

  188. Alexander RB, Maguire MG, Epstein JI, Walsh PC. Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate. J Urol. 1989 Apr;141(4):880-2.

  189. Walsh, P.C.: Radical retropubic prostatectomy with preservation of sexual function: An update after 500 cases. Distributed by Norwich Eaton Pharmaceuticals, Inc. Norwich, New York.

  190. Walsh, P.C.: EDITORIAL - One journal with everything. J. Urol. 141:194, 1989.

  191. Mohler JL, Erozan YS, Walsh PC, Epstein JI. Fine-needle core and aspiration biopsy. A new method for diagnosis of prostatic carcinoma. Cancer. 1989 May 1;63(9):1846-55.

  192. Walsh, P.C.: Radical prostatectomy with preservation of sexual function following wide unilateral excision of the neurovascular bundle. In Difficult Problems in Urologic Surgery, (ed) W. Scott McDougal, Year Book Medical Publishers, Chicago, 1988, pp. 185-93.

  193. Schlegel PN, Walsh PC. The use of the preperitoneal approach for the simultaneous repair of inguinal hernia during surgery on the bladder and prostate. World J Surg. 1989 Sep-Oct;13(5):555-9.

  194. Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol. 1989 Oct;142(4):1008-10.

  195. Carter, H.B., Partin, A.W., Oesterling, J.E., Weber, J.P., Epstein, J.I., Chan, D.W., Rock, R.C., and Walsh, P.C.: The use of prostate-specific antigen in the management of patients with prostate cancer: The Johns Hopkins Experience. In Clinical Aspects of Prostate Cancer, (eds) W.J. Catalona, D.S. Coffey, J.P. Karr, Elsevier Science Publishing Company, Inc., New York, 1989, pp. 247-51.

  196. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337-47.

  197. Walsh PC. Radical prostatectomy in locally confined prostatic carcinoma. Prog Clin Biol Res. 1990;359:199-207; discussion 223-9. Review.

  198. Walsh PC. Prostate carcinoma-current status and future direction. Nippon Hinyokika Gakkai Zasshi. 1990;81(13 Suppl):1978-9.

  199. Schlegel, P.N. and Walsh, P.C.: Impotence following radical prostatectomy. In COMMON PROBLEMS IN INFERTILITY AND IMPOTENCE (ed) Jacob Rajfer, Yearbook Medical Publishers, Chicago, 1990, pp. 356-361.

  200. Christensen WN, Partin AW, Walsh PC, Epstein JI. Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage. Cancer. 1990 Feb 15;65(4):1021-7. Review.

  201. Walsh PC, Brendler CB, Chang T, Marshall FF, Mostwin JI, Stutzman R, Schlegel PN. Preservation of sexual function in men during radical pelvic surgery. Md Med J. 1990 Apr;39(4):389-93.

  202. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Prostate specific antigen in the staging of localized prostate cancer:influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990 Apr;143(4):747-52.

  203. Walsh PC, Oesterling JE. Improved hemostasis during simple retropubic prostatectomy. J Urol. 1990 Jun;143(6):1203-4.

  204. Hamper UM, Epstein JI, Sheth S, Walsh PC, Sanders RC. Cystic lesions of the prostate gland. A sonographic--pathologic correlation. J Ultrasound Med. 1990 Jul;9(7):395-402.

  205. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am. 1990 Aug;17(3):461-75. Review.

  206. Walsh PC, Quinlan DM, Morton RA, Steiner MS. Radical retropubic prostatectomy. Improved anastomosis and urinary continence. Urol Clin North Am. 1990 Aug;17(3):679-84.

  207. Hamper UM, Sheth S, Walsh PC, Epstein JI. Bright echogenic foci in early prostatic carcinoma:sonographic and pathologic correlation. Radiology. 1990 Aug;176(2):339-43.

  208. Gearhart JP, Donohoue PA, Brown TR, Walsh PC, Berkovitz GD. Endocrine evaluation of adults with mild hypospadias. J Urol. 1990 Aug;144(2 Pt 1):274-7.

  209. Brendler CB, Schlegel PN, Walsh PC. Urethrectomy with preservation of potency. J Urol. 1990 Aug;144(2 Pt 1):270-3.

  210. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, Hamper U, Walsh PC, McNeil BJ. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med. 1990 Sep 6;323(10):621-6.

  211. Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1.

  212. Brendler CB, Steinberg GD, Marshall FF, Mostwin JL, Walsh PC. Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol. 1990 Nov;144(5):1137-40; discussion 1140-1.

  213. Hamper UM, Sheth S, Walsh PC, Holtz PM, Epstein JI. Carcinoma of the prostate:value of transrectal sonography in detecting extension into the neurovascular bundle. AJR Am J Roentgenol. 1990 Nov;155(5):1015-9.

  214. Steinberg GD, Epstein JI, Piantadosi S, Walsh PC. Management of stage D1 adenocarcinoma of the prostate:the Johns Hopkins experience 1974 to 1987. J Urol. 1990 Dec;144(6):1425-32.

  215. Walsh, P.C.: Prostate Cancer Update, Winter 1991 - Published by The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21205.

  216. Schlegel, P.N. and Walsh, P.C.: Preperitoneal hernia repair during urological surgery. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 114-18.

  217. Walsh, P.C. and Schlegel, P.N.: Radical cystectomy. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 129-42.176. Walsh, P.C.: Retropubic prostatectomy for benign and malignant diseases. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp.264-289.

  218. Brendler, C.B. and Walsh, P.C.: Urethrectomy with preservation of potency. In OPERATIVE UROLOGY, (ED) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 264-289.

  219. Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC. Familial risk factors for
    prostate cancer. Cancer Surv. 1991;11:5-13. Review.

  220. Carter HB, Brem RF, Tempany CM, Yang A, Epstein JI, Walsh PC, Zerhouni EA. Nonpalpable prostate cancer:detection with MR imaging. Radiology. 1991 Feb;178(2):523-5.

  221. Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol. 1991 Feb;145(2):380-3.

  222. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol. 1991 Feb;145(2):405-9.

  223. Hamper UM, Sheth S, Walsh PC, Holtz PM, Epstein JI. Capsular transgression of prostatic carcinoma:evaluation with transrectal US with pathologic correlation. Radiology. 1991 Mar;178(3):791-5.

  224. Marshall FF, Mostwin JL, Radebaugh LC, Walsh PC, Brendler CB. Ileocolic neobladder post-cystectomy:continence and potency. J Urol. 1991 Mar;145(3):502-4.

  225. Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol. 1991 Mar;145(3):512-4; discussion 514-5.

  226. Weber JP, Walsh PC, Peters CA, Spivak JL. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol. 1991 Mar;36(3):190-4.

  227. Sheth S, Hamper UM, Walsh PC, Holtz PM, Epstein JI. Stage A adenocarcinoma of the prostate:transrectal US and sonographic-pathologic correlation. Radiology. 1991 Apr;179(1):35-9.

  228. Christensen WN, Steinberg G, Walsh PC, Epstein JI. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991 Apr 15;67(8):2118-24.

  229. Vaughan ED Jr, Walsh PC. Prostate Health Council. Urology. 1991 May;37(5):501.

  230. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy:influence of preservation of neurovascular bundles. J Urol. 1991 May;145(5):998-1002.

  231. Bastacky SS, Walsh PC, Epstein JI. Needle biopsy associated tumor tracking of adenocarcinoma of the prostate. J Urol. 1991 May;145(5):1003-7.

  232. Morton RA, Steiner MS, Walsh PC. Cancer control following anatomical radical prostatectomy:an interim report. J Urol. 1991 Jun;145(6):1197-200.

  233. Sadi MV, Walsh PC, Barrack ER. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer. 1991 Jun 15;67(12):3057-64.

  234. Carter, H.B. and Walsh, P.C.: Stage A1 prostatic adenocarcinoma. In Current Therapy in Genitourinary Surgery, 2nd Edition, (eds) Martin I. Resnick and Elroy D. Kursh; B.C. Decker, Mosby Year Book, Inc., St. Louis, MO, 1992, pp. 103-5.

  235. Hamper UM, Sheth S, Walsh PC, Holtz PM, Epstein JI. Stage B adenocarcinoma of the prostate:transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions. Radiology. 1991 Jul;180(1):101-4.

  236. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol. 1991 Aug;146(2):463-8.

  237. Tempany CM, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer:evaluation with MR imaging. Radiology. 1991 Oct;181(1):107-12.

  238. Ness PM, Walsh PC, Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion. 1992 Jan;32(1):31-6.

  239. Ness PM, Bourke DL, Walsh PC. A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion. 1992 Mar-Apr;32(3):226-30.

  240. Walsh PC. Why make an early diagnosis of prostate cancer. J Urol. 1992 Mar;147(3 Pt 2):853-4.

  241. Walsh, P.C.: Benign prostatic hyperplasia. In Campbell’s Textbook of Urology, 6th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 1, pp. 1009-27.

  242. Stutzman, R.E. and Walsh, P.C..: Suprapubic and retropubic prostatectomy. In Campbell’s Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 3, pp. 2851-2864.

  243. Walsh, P.C.: Radical retropubic prostatectomy. In Campbell’s Textbook of Urology, 6th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 3, pp. 2865-86.

  244. Borland RN, Walsh PC. The management of rectal injury during radical retropubic prostatectomy. J Urol. 1992 Mar;147(3 Pt 2):905-7.

  245. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3367-71.

  246. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992 Apr 22-29;267(16):2215-20.

  247. Carter HB, Morrell CH, Pearson JD, Brant LJ, Plato CC, Metter EJ, Chan DW, Fozard JL, Walsh PC. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res. 1992 Jun 15;52(12):3323-8.

  248. Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. J Urol. 1992 Jul;148(1):87-91. Review.

  249. Walsh, P.C.: Radical retropubic prostatectomy: An anatomic approach. Campbell’s Urology Sixth Edition, Update 1, pp. 1-13, 1992

  250. Brendler CB, Walsh PC. The role of radical prostatectomy in the treatment of prostate cancer. CA Cancer J Clin. 1992 Jul-Aug;42(4):212-22.

  251. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med. 1992 Oct 22;327(17):1185-91.

  252. Rahmouni, A., Yang, A., Tempany, C.M.C., Frenkel, T., Epstein, J., Walsh, P., Leichner, P.K., Ricci, C. and Zerhouni, E.: Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J. Computer Assisted Tomography 16:935-40.

  253. Burnett AL, Chan DW, Brendler CB, Walsh PC. The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer. J Urol. 1992 Dec;148(6):1832-4.

  254. Walsh, P.C., Burnett, A.L., and Partin, A.W.: Anatomical radical retropubic prostatectomy: Evolution of the surgical technique. Highlights of the Audio-Visual Presentation, March 1993 Booklet, Creative Medical Communication, New York, NY.

  255. Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate. 1993;22(1):39-42.

  256. Quinlan DM, Stutzman RE, Peters CA, Walsh PC. Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma. Urology. 1993 Apr;41(4):308-10.

  257. Walsh PC. The effect of finasteride in men with benign prostatic hyperplasia. J Urol. 1993 Apr;149(4):932-3.

  258. Bastacky SI, Walsh PC, Epstein JI. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol. 1993 Apr;17(4):336-41.

  259. Epstein JI, Carmichael M, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle:definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993 May;149(5):1040-5.

  260. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993 Jun;149(6):1478-81.

  261. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 1993 Jun 1;71(11):3582-93.

  262. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993 Jul;150(1):110-4.

  263. Burnett AL, Tillman SL, Chang TS, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol. 1993 Jul;150(1):73-6.

  264. Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy:a study of 196 cases with long-term followup. J Urol. 1993 Jul;150(1):135-41.

  265. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer:epidemiologic and clinical features. J Urol. 1993 Sep;150(3):797-802. Review.

  266. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 1993 Sep 1;53(17):3869-73.

  267. Cisek LJ, Walsh PC. Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices. Urology. 1993 Oct;42(4):406-8.

  268. Walsh PC. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J Urol. 1993 Oct;150(4):1330-2.

  269. Walsh PC. Disease-specific survival following routine prostate cancer screening by digital rectal examination. J Urol. 1993 Oct;150(4):1328-9.

  270. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am. 1993 Nov;20(4):713-25.

  271. Walsh, P.C.: Editorial - The heterogeneity of benign prostatic hyperplasia. J. Urol. 150:1587, 1993.

  272. Walsh PC. Using prostate-specific antigen to diagnose prostate cancer:sailing in uncharted waters. Ann Intern Med. 1993 Nov 1;119(9):948-9.

  273. Walsh PC, Partin AW. Treatment of early stage prostate cancer:radical prostatectomy. Important Adv Oncol. 1994;:211-23. Review.

  274. Gormley, G.J., Ng., J., Cook, T., Stoner, E., Guess, H. and Walsh, P.C.: Effect of finasteride on prostate-specific antigen density. Urol. 43:53-60, 1994.

  275. Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC, Barrack ER. Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun. 1994 Jan 14;198(1):74-80.

  276. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994 Feb 2;271(5):368-74.

  277. Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 1994 May;43(5):649-59.

  278. Epstein JI, Carmichael MJ, Partin AW, Walsh PC. Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease:pathogenetic and clinical implications. J Urol. 1994 Jun;151(6):1587-92.

  279. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI. Radical prostatectomy for high grade disease:a reevaluation 1994. J Urol. 1994 Jun;151(6):1583-6.

  280. Partin AW, Walsh PC. Re:The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1994 Jul;152(1):172-3.

  281. Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC. Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994 Jul;152(1):115-9.

  282. Walsh, P.C.: Prostate Cancer Update, Vol. III, #1, Spring 1994 - Published by the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101.

  283. Walsh PC. Results of conservative management of clinically localized prostate cancer. J Urol. 1994 Jul;152(1):255-6.

  284. Walsh PC. Prostate cancer kills:strategy to reduce deaths. Urology. 1994 Oct;44(4):463-6. Review.

  285. Walsh PC. Radical prostatectomy:a procedure in evolution. Semin Oncol. 1994 Oct;21(5):662-71. Review.

  286. Hedican SP, Walsh PC. Postoperative bleeding following radical retropubic prostatectomy. J Urol. 1994 Oct;152(4):1181-3.

  287. Walsh,P.C.: Technique of vesicourethral anastomosis may influence recovery of sexual function following radical prostatectomy. In Atlast of the Urologic Clinics of North America, vol. 2, #2, pp. 59-64, October 1994.

  288. Sgrignoli AR, Walsh PC, Steinberg GD, Steiner MS, Epstein JI. Prognostic factors in men with stage D1 prostate cancer:identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol. 1994 Oct;152(4):1077-81.

  289. Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC. Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology. 1994 Nov;44(5):646-50.

  290. Epstein JI, Walsh PC, Brendler CB. Radical prostatectomy for impalpable prostate cancer:the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C) J Urol. 1994 Nov;152(5 Pt 2):1721-9. Review.

  291. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy:results at 10 years. J Urol. 1994 Nov;152(5 Pt 2):1831-6.

  292. Walsh PC. The status of radical prostatectomy in the United States in 1993:where do we go from here? J Urol. 1994 Nov;152(5 Pt 2):1816.

  293. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol. 1995 Mar;153(3 Pt 2):987-92.

  294. Carmichael MJ, Veltri RW, Partin AW, Miller MC, Walsh PC, Epstein JI. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. J Urol. 1995 Mar;153(3 Pt 2):1015-9.

  295. Walsh, P.C.: Risk factors for prostate cancer: Is it possible to identify a high-risk population? In 4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceeding, Paris, 1994, (eds) G. Murphy, S. Khoury, C. Chatelain, L. Denis, Scientific Communication International Ltd., Jersey, Cahnnel Islands, 1994, pp. 46-50.

  296. Walsh, P.C. and Epstein, J.I.: Radical prostatectomy and positive surgical margins: When, where, and what to do? In 4th International Symposium on Recent Advances in Urological Cancer diagnosis and Treatment Proceeding, Paris, 1994, (eds) G. Murphy, S. Khoury, C. Chatelain, L. Denis, Scientific Communicaton International Ltd., Jersey, Channel Islands, 1994, pp. 199-207.

  297. Walsh, P.C.: The natural history of localized prostate cancer: A guide to therapy. Campbell’s Urology, Sixth Edition, Update 13, pp. 1-8, 1995.

  298. Carter HB, Pearson JD, Waclawiw Z, Metter EJ, Chan DW, Guess HA, Walsh PC. Prostate-specific antigen variability in men without prostate cancer:effect of sampling interval on prostate-specific antigen velocity. Urology. 1995 Apr;45(4):591-6.

  299. Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC, Simons JW. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology. 1995 May;45(5):831-8.

  300. Berges RR, Vukanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, Veltri RW, Walsh PC, Isaacs JT. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res. 1995 May;1(5):473-80.

  301. Scher, H.I., Isaacs, J.T., Fuks, Z., and Walsh, P.C.: Prostate. In Clinical Oncology, 1995. (Eds) M.D. Abeloff, J.O. Armitage, A.S. Lichter, John E. Niederhuber, 1995, pp. 1439-1472.

  302. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate. 1995 Jul;27(1):25-31.

  303. Walsh PC. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. J Urol. 1995 Jul;154(1):301.

  304. Polascik TJ, Walsh PC. Radical retropubic prostatectomy:the influence of accessory pudendal arteries on the recovery of sexual function. J Urol. 1995 Jul;154(1):150-2.

  305. Isaacs S.D, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 1995 Jul 5;87(13):991-6.

  306. Riopel, M.A., Polascik, T.J., Partin, A.W, Sauvageot, J., Walsh, P.C., and Epstein, J.I.: Radical prostatectomy in men less than 50 years old. Urol. Oncol. 1:80-83, 1995.

  307. Quinlan DM, Partin AW, Walsh PC. Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? Urology. 1995 Sep;46(3 Suppl A):77-82. Review.

  308. Walsh PC. Re:Potency-sparing radical retropubic prostatectomy:a simplified anatomical approach. J Urol. 1996 Jan;155(1):294.

  309. Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer:10-year followup. J Urol. 1996 Feb;155(2):490-4.

  310. Schoenberg M, Kiemeney L, Walsh PC, Griffin CA, Sidransky D. Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma. J Urol. 1996 Mar;155(3):1035-6.

  311. Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 1996 Mar;20(3):286-92.

  312. Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer:A pathological analysis. J Urol. 1996 Apr;155(4):1336-9.

  313. Walsh PC. RE:Prostate specific antigen after gonadal androgen withdrawal and deferred flutamide treatment. J Urol. 1996 May;155(5):1705.

  314. Walsh PC. Re:Quality of life:radical prostatectomy versus radiation therapy for prostate cancer. J Urol. 1996 Jun;155(6):2038-9.

  315. Niesel T, Partin AW, Walsh PC. Anatomic approach for placement of surgical drains after radical retropubic prostatectomy:long-term effects on postoperative pain. Urology. 1996 Jul;48(1):91-4.

  316. Schlegel, P.N. and Walsh, P.C.: Preperitoneal hernia repair during urological surgery. In TEXTBOOK OF OPERATIVE UROLOGY, (eds) F.F. Marshall, L.R. Kavoussi, J.W. McAninch, C.A. Peters; W.B. Saunders Co., Philadelphia, 1996, pp. 381-85.

  317. Walsh PC. Follow-up prostate cancer treatments after radical prostatectomy:a population-based study. J Urol. 1996 Jul;156(1):301-2.

  318. Walsh PC. The definition and preoperative prediction of clinically insignificant prostate cancer. J Urol. 1996 Jul;156(1):300-1.

  319. Epstein JI, Walsh PC, Sanfilippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol. 1996 Jul;20(7):851-7.

  320. Walsh PC. Treatment of benign prostatic hyperplasia. N Engl J Med. 1996 Aug 22;335(8):586-7.

  321. Doehring CB, Sanda MG, Partin AW, Sauvageot J, Juo H, Beaty TH, Epstein JI, Hill G, Walsh PC. Histopathologic characterization of hereditary benign prostatic hyperplasia. Urology. 1996 Oct;48(4):650-3.

  322. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996 Nov 22;274(5291):1371-4.

  323. Partin, A.W. and Walsh, P.C.: Management of stage B (T1c-T2) Prostate Cancer. In Principles and Practice of Genitourinary Oncology (eds) D. Raghavan, H.I. Scher, S.A. Leibel, and P.H. Lange, Lippincott-Raven, Philadelphia, 1997, pp. 499-508.

  324. Pound CR, Walsh PC, Epstein JI, Chan DW, Partin AW. Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer. World J Urol. 1997;15(6):373-7.

  325. Walsh PC, Brooks JD. The Swedish prostate cancer paradox. JAMA. 1997 Feb 12;277(6):497-8.

  326. Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Clinical and biological characteristics of familial benign prostatic hyperplasia. J Urol. 1997 Mar;157(3):876-9.

  327. Walsh PC. Re:Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol. 1997 Mar;157(3):965.

  328. Walsh PC. Is prostate cancer screening analogous to lung cancer screening? JAMA. 1997 Apr 9;277(14):1121; discussion 1121-2.

  329. Thiel R, Pearson JD, Epstein JI, Walsh PC, Carter HB. Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer. Urology. 1997 May;49(5):716-20.

  330. Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am. 1997 May;24(2):395-406.

  331. Walsh, P.C. and Worthington, J.F.: Prostate Cancer Update, vol IV, #1:1-16, Spring 1997.

  332. Walsh PC. Localized prostate cancer-mortality and morbidity. J Urol. 1997 May;157(5):1773.

  333. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997 May 14;277(18):1445-51.

  334. Carter HB, Sauvageot J, Walsh PC, Epstein JI. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol. 1997 Jun;157(6):2206-9. Review.

  335. Walsh, P.C.: Anatomic radical prostatectomy: Cancer control with preservation of quality of life. Presented at the General Motors Cancer Research Foundation Awards Ceremony, June 1996. Published in Accomplishments in Cancer Research 1996, (eds) Fortner, J.G., and Sharp, P.A., Lippincott-Raven Publishers, Philadelphia and New York, 1997, pp. 41-53.

  336. Walsh, P.C.: The natural history of localized prostate cancer: A guide to therapy. In Campbell’s Textbook of Urology, Seventh Edition, (eds) Walsh, P.C., Retik, A.B., Vaughan, Jr., E.D., and Wein, A.J.; W.B. Saunders, Phildelphia, 1997, pp. 2539-2546.

  337. Walsh, P.C.: Anatomic radical retropubic prostatectomy. In Campbell’s Textbook of Urology, Seventh Edition, (eds) Walsh, P.C., Retik, A.B., Vaughan, Jr., E.D., and Wein, A.J., W.B. Saunders, Philadelphia, 1997, pp. 2565-2587.

  338. Cadeddu JA, Partin AW, Epstein JI, Walsh PC. Stage D1 (T1-3, N1-3, M0) prostate cancer:a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 1997 Aug;50(2):251-5.

  339. Walsh PC. Screening for prostate cancer. American College of Physicians. J Urol. 1997 Oct;158(4):1617.

  340. Walsh PC. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer:a multi-institutional update. J Urol. 1997 Oct;158(4):1618-9.

  341. Walsh PC. Immediate versus deferred treatment for advanced prostatic cancer:initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. J Urol. 1997 Oct;158(4):1623-4.

  342. Gronberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, Xu J, Meyers DA, Collins FS, Trent JM, Walsh PC, Isaacs WB. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA. 1997 Oct 15;278(15):1251-5.

  343. Epstein JI, Walsh PC, Sauvageot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol. 1997 Nov;158(5):1886-90.

  344. Gronberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, Bova GS, Danber JE, Bergh A, Walsh PC, Collins FS, Trent JM, Meyers DA, Isaacs WB. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res. 1997 Nov 1;57(21):4707-9.

  345. Walsh, P.C.: The prostate and male pelvis. In The Johns Hopkins Atlas of Human Functional Anatomy. (ed) G.D. Zuidema, The Johns Hopkins University Press, Baltimore and London, 1997, pp. 155-156.

  346. Walsh PC, Partin AW. Family history facilitates the early diagnosis of prostate carcinoma. Cancer. 1997 Nov 1;80(9):1871-4.

  347. Page, W.F., Braun, M.M., Partin, A.W., Caporaso, N., and Walsh, P.C.: Heredity and prostate cancer: A study of World War II veteran twins. The Prostate 33:240-245, 1997.

  348. Walsh PC. Conflict of interest or widely held misconception? Urology. 1997 Dec;50(6):1028.

  349. McConnell, J.D., Bruske, R., Walsh, P.C., Andriole, G., Lieber, M., Holtgrewe, H.L., Albertsen, P., Roehrborn, C.G., Nickel, J.C., Wang, D.Z., Taylor, A.M., & Waldstreicher for the Finasteride Long-term Efficacy and Safety Study Group. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. NEJM 338:557-63, 1998.

  350. Walsh PC. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Urol. 1998 Jan;159(1):308-9.

  351. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 1998 Jan;159(1):173-7; discussion 177-8.

  352. Pannek J, Rittenhouse HG, Chan DW, Epstein JI, Walsh PC, Partin AW. The use of percent free prostate specific antigen for staging clinically localized prostate cancer. J Urol. 1998 Apr;159(4):1238-42. Review.

  353. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease:a prospective multicenter clinical trial. JAMA. 1998 May 20;279(19):1542-7.

  354. Polascik TJ, Pound CR, DeWeese TL, Walsh PC. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer:a 7-year biochemical (PSA) progression analysis. Urology. 1998 Jun;51(6):884-9; discussion 889-90. Review.

  355. Glover FE Jr, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC. The epidemiology of prostate cancer in Jamaica. J Urol. 1998 Jun;159(6):1984-6; discussion 1986-7.

  356. Walsh PC. Intermittent androgen deprivation for clinically localized prostate cancer:initial experience. J Urol. 1998 Jul;160(1):270-1.

  357. Walsh PC. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. J Urol. 1998 Jul;160(1):265-6.

  358. Epstein JI, Pound CR, Partin AW, Walsh PC. Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol. 1998 Jul;160(1):97-100; discussion 101.

  359. Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC. Influence of radical prostatectomy on serum hormone levels. J Urol. 1998 Aug;160(2):449-53.

  360. Glover FE Jr, Coffey DS, Douglas LL, Russell H, Cadigan M, Tulloch T, Wedderburn K, Wan RL, Baker TD, Walsh PC. Familial study of prostate cancer in Jamaica. Urology. 1998 Sep;52(3):441-3.

  361. Bova GS, Partin AW, Isaacs SD, Carter BS, Beaty TL, Isaacs WB, Walsh PC. Biological aggressiveness of hereditary prostate cancer:long-term evaluation following radical prostatectomy. J Urol. 1998 Sep;160(3 Pt 1):660-3.

  362. Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB. Nonpalpable stage T1c prostate cancer:prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol. 1998 Dec;160(6 Pt 2):2407-11. Review.

  363. Walsh PC. Anatomic radical prostatectomy:evolution of the surgical technique. J Urol. 1998 Dec;160(6 Pt 2):2418-24.

  364. Argani P, Walsh PC, Epstein JI. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures:further evidence of the mesodermal origin of the prostatic central zone. J Urol. 1998 Dec;160(6 Pt 1):2126-9.

  365. Eisenberger CF, Walsh PC, Eisenberger MA, Chow NH, Partin AW, Mostwin JL, Marshall FF, Epstein JI, Schoenberg M. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology. 1999 Jan;53(1):175-9.

  366. Walsh PC. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. J Urol. 1999 Jan;161(1):357-8.

  367. Walsh PC. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer:results of a randomized, double-blind, placebo-controlled clinical trial. J Urol. 1999 Jan;161(1):350-1.

  368. Holmes GF, Walsh PC, Pound CR, Epstein JI. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology. 1999 Apr;53(4):752-6.

  369. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999 May 5;281(17):1591-7.

  370. Wilkens EP, Freije D, Xu J, Nusskern DR, Suzuki H, Isaacs SD, Wiley K, Bujnovsky P, Meyers DA, Walsh PC, Isaacs WB. No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate. 1999 Jun 1;39(4):280-4.

  371. Feneley MR, Walsh PC. Incontinence after radical prostatectomy. Lancet. 1999 Jun 19;353(9170):2091-2.

  372. Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol. 1999 Oct;162(4):1337-40.

  373. Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen:a prospective multicenter clinical trial. J Urol. 1999 Oct;162(4):1346-51.

  374. Epstein JI, Walsh PC, Akingba G, Carter HB. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol. 1999 Nov;162(5):1649-52.

  375. Eisenberger MA, Walsh PC. Early androgen deprivation for prostate cancer? N Engl J Med. 1999 Dec 9;341(24):1837-8.

  376. Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, Schellhammer PF, Bruskewitz R, Matsumoto AM, Harrison LH, Fuselier HA, Walsh PC, Roy J, Andriole G, Resnick M, Waldstreicher J. For the PLESS Study Group. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. (Presented during 1998 American Urological Association Meeting, San Diego). J Urol 2000 Jan;163:13-20.

  377. Walsh PC, Marschke P, Ricker D, Burnett AL. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy. Urology. 2000 Jan;55(1):62-7.

  378. Walsh, P.C.: Prostate Cancer Update, Vol.V, #1, Winter 2000 - Published by the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101.

  379. Glover, F.E., Walsh, P.C., and Carter, H.B.: Epidemiology of prostate cancer in Jamaicans. In Advanced Therapy of Prostate Disease, (eds) Resnick, M.I. and Thompson, I.A., Hamilton & London, 2000, pp. 28-30.

  380. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000 Jan;55(1):58-61.

  381. Walsh PC. Cancer surveillance series:interpreting trends in prostate cancer--part I:evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Urol. 2000 Jan;163(1):364-5.

  382. Walsh PC. Sexual function and bother after radical prostatectomy or radiation for prostate cancer:multivariate quality-of-life analysis from CaPSURE. J Urol. 2000 Jan;163(1):370.

  383. Catalona WJ, Partin AW, Slawin KM, Naughton CK, Brawer MK, Flanigan RC, Richie JP, Patel A, Walsh PC, Scardino PT, Lange PH, deKernion JB, Southwick PC, Loveland KG, Parson RE, Gasior GH. Percentage of free PSA in black versus white men for detection and staging of prostate cancer:a prospective multicenter clinical trial. Urology. 2000 Mar;55(3):372-6.

  384. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life:a structured debate. J Urol. 2000 Jun;163(6):1802-7.

  385. Rodriguez R, Walsh PC. Trousseau's syndrome in a patient with metastatic prostate cancer. J Urol. 2000 Jun;163(6):1877.

  386. Han M, Walsh PC, Partin AW, Rodriguez R. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease. J Urol. 2000 Jul;164(1):89-92.

  387. Walsh PC. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol. 2000 Jul;164(1):242.

  388. Walsh PC. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. J Urol. 2000 Jul;164(1):246-7.

  389. Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Loveland KG, Bray KR. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology. 2000 Aug 1;56(2):255-60.

  390. Epstein JI, Partin AW, Potter SR, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle:prognostic stratification based on pathologic parameters. Urology. 2000 Aug 1;56(2):283-8.

  391. Walsh PC. Re:radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Oct;164(4):1322-3.

  392. Chan TY, Partin AW, Walsh PC, Epstein JI. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology. 2000 Nov 1;56(5):823-7.

  393. Feneley MR, Landis P, Simon I, Metter EJ, Morrell CH, Carter HB, Walsh PC. Today men with prostate cancer have larger prostates. Urology. 2000 Nov 1;56(5):839-42.

  394. Bahnson RR, Hanks GE, Huben RP, Kantoff P, Kozlowski JM, Kuettel M, Lange PH, Logothetis C, Pow-Sang JM, Roach M 3rd, Sandler H, Scardino PT, Taylor RJ, Urban DA, Walsh PC, Wilson TG. NCCN Practice Guidelines for Prostate Cancer. Oncology (Huntingt). 2000 Nov;14(11A):111-9.

  395. Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 2000 Nov;164(5):1591-5.

  396. Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell KL, Epstein JI, Walsh PC, Partin AW. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy. Cancer. 2000 Dec 15;89(12):2577-86.

  397. Han M, Snow PB, Epstein JI, Chan TY, Jones KA, Walsh PC, Partin AW. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology. 2000 Dec 20;56(6):994-9.

  398. Walsh PC. Modern prostate brachytherapy:prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. J Urol. 2001 Jan;165(1):318-9.

  399. Walsh PC, Marschke P, Catalona WJ, Lepor H, Martin S, Myers RP, Steiner MS. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy:a multi-institutional evaluation by experienced surgeons. Urology. 2001 Mar;57(3):491-4.

  400. Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins:therapeutic implications. J Urol. 2001 Mar;165(3):864-6.

  401. Walsh PC. Letter to the Editor: Re: Radical prostatectomy:the value of preoperative, individually labeled apical biopsies. J Urol. 2001 Mar;165(3):915.

  402. Han M, Piantadosi S, Zahurak ML, Sokoll LJ, Chan DW, Epstein JI, Walsh PC, Partin AW. Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer. Urology. 2001 Apr;57(4):707-11.

  403. Xu J, Zheng SL, Chang B, Smith JR, Carpten JD, Stine OC, Isaacs SD, Wiley KE, Henning L, Ewing C, Bujnovszky P, Bleeker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet. 2001 Apr;108(4):335-45.

  404. Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey-Wilson J, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Evaluation of linkage and association of HPC2/ELA